GSK, US PTO reach agreement to dismiss litigation over Final Regulations

GlaxoSmithKline has reached agreement with the United States Patent and Trademark Office (US PTO) to join the US PTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J Kappos and the United States Patent and Trademark Office). GSK and the US PTO will file a joint motion with the US Court of Appeals for the Federal Circuit to dismiss the litigation and to vacate the previous decision in this case by the US District Court for the Eastern District of Virginia. The US PTO is withdrawing all regulations under dispute.